This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ayman Saad - Innovator in Stem Cell Transplantation
Introduction
Ayman Saad is an inventor based in Hoover, AL (US). He is currently associated with The UAB Research Foundation. Although he has not yet been granted any patents, his work focuses on significant advancements in the field of hematopoietic stem cell transplantation.
Latest Patent Applications
Ayman Saad has submitted several patent applications related to methods for stem cell transplantation. One of his latest applications details a method of HSCT using a combination of an in-vivo T-cell depletion method and an ex-vivo method of γδ T cell expansion and αβ T cell depletion. This innovative approach aims to deplete alloreactive T cells in vivo, which could otherwise increase the risk of graft-versus-host disease (GvHD). Another application also focuses on similar methodologies for improving HSCT outcomes.
Conclusion
Ayman Saad is making strides in the field of stem cell transplantation through his innovative research and patent applications. His contributions could potentially lead to significant advancements in medical treatments for patients requiring stem cell transplants.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile